Suchergebnisse - "145155-23-3"

PubPharm (903)

1

Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis : A Case Report and Review of Literature

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Akita, S. | Fujibayashi, K. | Ueno, E. | +3

2

Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis

enthalten in: Molecules (Basel, Switzerland) | 2022

von Ortíz, G. | Briones-Torres, A. | Benitez-King, G. | +3

3

Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study

enthalten in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2022

von Korobko, D. | Barabanova, M. | Bakhtiyarova, K. | +4

4

Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b : post-hoc analysis of a 2-year, prospective, international, observational study

enthalten in: BMC neurology | 2021

von Patti, F. | Penaherrera, J. | Zieger, L. | +1

5

The results of an open comparative retrospective trial of the course of multiple sclerosis during treatment with infibeta and other interferon-beta bioanalogues and glatiramer acetate

enthalten in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2018

von Khabirov, F. | Khaybullin, T. | Granatov, E. | +8

6

Cost-Effectiveness of Peginterferon Beta-1a and Alemtuzumab in Relapsing-Remitting Multiple Sclerosis

enthalten in: Journal of managed care & specialty pharmacy | 2017

von Dashputre, A. | Kamal, K. | Pawar, G.

7

The cross-reactivity of binding antibodies with different interferon beta formulations used as disease-modifying drugs in multiple sclerosis patients

enthalten in: Medicine | 2016

von Wencel-Warot, A. | Michalak, S. | Warot, M. | +2

8

A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

enthalten in: Annals of neurology | 2015

von Esposito, F. | Sorosina, M. | Ottoboni, L. | +19

CommentIn: Nat Rev Neurol. 2015 Jul;11(7):371-2. - PMID 26077840

9

Pregnancy outcomes in patients exposed to interferon beta-1b

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2015

von Romero, R. | Lünzmann, C. | Bugge, J.

10

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course : a comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs

enthalten in: Clinical immunology (Orlando, Fla.) | 2015

von Gibbs, E. | Karim, M. | Oger, J. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[91]